Integration Depth Determines Scribe Moat
Brendan Keeler, interoperability lead at HTD Health, on GTM for AI medical scribes
The real moat in AI medical scribes is not hearing the visit, it is finishing the visit inside the EHR. A product that only drafts a note still leaves the clinician clicking through diagnoses, orders, flow sheets, and billing fields. The winner is the vendor that can take one conversation and turn it into the full chain of structured work that actually closes the encounter, especially in Epic and other deeply embedded systems.
-
This is why enterprise scribes pull ahead of self serve tools. In small practices, copy and paste notes can be good enough at first. In larger systems, the product has to write into the chart, suggest or queue orders, populate discrete fields, and satisfy IT, compliance, and business associate agreement requirements.
-
Abridge built its position by going very deep with Epic, where integration matters more than raw transcription quality. That depth helped it scale to 60,000 clinicians and about $100M ARR by May 2025, while bottom up players like Freed grew quickly with a lighter $99 per month product and then started expanding into pre charting and coding.
-
Depth also changes by care setting. Outpatient visits are repeatable and easier to map into a note, diagnosis list, and orders. Inpatient care, the ER, ICU, surgery, and nursing rounds involve more chaotic workflows, more handoffs, and more varied documentation, so the next frontier is not better listening alone, it is workflow specific automation.
From here, the market moves from ambient scribe to ambient admin. Products that can reliably complete more of the downstream tasks, first in outpatient and then in selected inpatient workflows, will become part of the EHR operating layer rather than a transcription add on. That is where pricing power, expansion, and staying power are likely to concentrate.